Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
Schmidt CQ, Harder MJ, Nichols EM, Hebecker M, Anliker M, Höchsmann B, Simmet T, Csincsi ÁI, Uzonyi B, Pappworth IY, Ricklin D, Lambris JD, Schrezenmeier H, Józsi M, Marchbank KJ.
Schmidt CQ, et al. Among authors: harder mj.
Immunobiology. 2016 Apr;221(4):503-11. doi: 10.1016/j.imbio.2015.12.009. Epub 2016 Jan 6.
Immunobiology. 2016.
PMID: 26792457
Free PMC article.